# Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours of Onset With Tenecteplase (RITIS-TNK2)

Study · id `cardio:ct-nct07375966` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07375966](<https://clinicaltrials.gov/study/NCT07375966>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07375966

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 198 participants.

## Technical summary

Registry record NCT07375966. Randomized; single masking; primary purpose treatment. Start 2026-03-25 (actual); primary completion 2027-12-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 198 participants (planned count; ClinicalTrials.gov record NCT07375966, source copy `cardio:ctgov-nct07375966-2026-04-01`, retrieved 2026-10-26)
- Started: 2026-03-25 (actual) (ClinicalTrials.gov record NCT07375966, source copy `cardio:ctgov-nct07375966-2026-04-01`, retrieved 2026-10-26)
- Primary completion: 2027-12-30 (anticipated) (ClinicalTrials.gov record NCT07375966, source copy `cardio:ctgov-nct07375966-2026-04-01`, retrieved 2026-10-26)
- Completion: 2027-12-30 (anticipated) (ClinicalTrials.gov record NCT07375966, source copy `cardio:ctgov-nct07375966-2026-04-01`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT07375966, source copy `cardio:ctgov-nct07375966-2026-04-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07375966-2026-04-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours of Onset With Tenecteplase (RITIS-TNK2)
- Acronym: RITIS-TNK2
- Condition: Ischemic Stroke
- Intervention (Drug): Tenecteplase
- Lead sponsor: General Hospital of Shenyang Military Region
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Tenecteplase (`cardio:tenecteplase`)
- Registry intervention is a member of this class by a sourced record link: Fibrinolytic (clot-dissolving) drugs (`cardio:fibrinolytic-clot-dissolving-drugs`)
- Registry lists this organization as the lead sponsor: General Hospital of Shenyang Military Region (`cardio:org-general-hospital-of-shenyang-military-region`)

## Provenance

Content hash: 910a1d26e33840c17997e9e244d8ab014c3132bab229722410d503f9dbeb5a82
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
